Diagnos Inc.

DIAGNOS Provides an Update on Sales and Regulatory Activities for CARA

DIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration

DIAGNOS Announces Amendments to Convertible Debentures and Stock Warrants

DIAGNOS to present at Centurion One Capital 9th Annual Toronto Growth Conference

DIAGNOS and ÉTS Announce $1M+ Federal Investment to Propel Next-Generation Retinal AI Innovation